<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS TWELVE MONTHS YEAR-TO-DATE SUMMARY FINANCIAL INFORMATION EXTRACTED FROM AMERICAN BIOGENETIC SCIENCES, INC. 1998 10-K FOR THE YEAR ENDED DECEMBER 31, 1998. </LEGEND> <CIK> 0000856984 <NAME> AMERICAN BIOGENETIC SCIENCES, INC. <PERIOD-TYPE> 12-MOS <FISCAL-YEAR-END> DEC-31-1998 <PERIOD-END> DEC-31-1998 <CASH> 3,047,000 <SECURITIES> 0 <RECEIVABLES> 177,000 <ALLOWANCES> 0 <INVENTORY> 545,000 <CURRENT-ASSETS> 40,000 <PP&E> 2,349,000 <DEPRECIATION> 1,718,000 <TOTAL-ASSETS> 6,514,000 <CURRENT-LIABILITIES> 862,000 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 39,000 <OTHER-SE> 5,557,000 <TOTAL-LIABILITY-AND-EQUITY> 6,514,000 <SALES> 1,197,000 <TOTAL-REVENUES> 1,197,000 <CGS> 465,000 <TOTAL-COSTS> 465,000 <OTHER-EXPENSES> 2,161,000 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 614,000 <INCOME-PRETAX> (6,408,000) <INCOME-TAX> 0 <INCOME-CONTINUING> (6,408,000) <DISCONTINUED> 0 <EXTRAORDINARY> (1,140,000) <CHANGES> 0 <NET-INCOME> (7,548,000) <EPS-PRIMARY> (.29) <EPS-DILUTED> (.29)